Sunbird Bio is a leader in protein-based diagnostic tests, becoming the first company to overcome the challenge of accurately detecting and differentiating the specific proteins that aggregate, and therefore signal the presence of Alzheimer’s disease, with a simple blood draw. We are addressing the tremendous, growing need for more reliable and sensitive diagnostic tests to accelerate drug development and enhance patient care. Our pipeline of innovative, non-invasive technologies, such as our APEX technology, will empower researchers and clinicians with unparalleled insights not available from current tests.
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Founded date: 2021
Investors 4
| Date | Name | Website |
| - | ARCH Ventu... | archventur... |
| - | S32 | s32.com |
| - | Rivas Capi... | rivascap.c... |
| - | DNS Capita... | dnscap.com |
Mentions in press and media 1
| Date | Title | Description | Source |
| 15.09.2022 | ClavystBio launches to translate life sciences breakthroughs... | ClavystBio will invest and work with partners to accelerate life sciences commercialisation in Singa... | en.prnasia... |